GSK (GLAXOSMITHKLINE P)
All Pro Portfolios with GSK
- Total Pro Portfolios with GSK:
- Allianz NFJ Dividend Value Instl NFJEX
- Dodge & Cox
- Dodge & Cox Stock (DODGX)
- WisdomTree Intl Consumer Non-Cyclical Fund (DPN)
- Homestead Value - HOVLX
- Oakmark International Fund (OAKIX)
- show more
- 12
- Kinetics Medical MEDRX
- Tweedy Browne
- BAM Capital
- Vanguard PRIMECAP Core - VPCCX
- Dodge & Cox International Stock DODFX
- Charles Brandes
All Do-It-Yourself Portfolios with GSK
- Total Do-It-Yourself Portfolios with GSK:
- Vitaliy's Top Stocks
- Jim Profit
- Christina Agnew Portfolio 1
- bdove
- biosci
- schwab trust
- Jim Bufkins Portfolio 1
- Manny Mendelson Portfolio 1
- FJS Portfolio 1
- run today
- Roger1000 Portfolio 1
- samkati Portfolio 1
- kpennick1
- john matera Portfolio 1
- Phil Kempton Portfolio 1
- SPIKES BIG
- bobbi Portfolio 1a
- Nish Deodhar Portfolio 1
- JohnnyRocker Portfolio 1
- Today
- machoger
- mark one
- Catherine Meyerholtz Portfolio 1
- Ulrath_the_Unclean Portfolio 1
- Top Yielding Healthcare Stocks
- Stallion Capital
- semtax Portfolio 1
- helen
- tapin67
- erbarden Portfolio 1
- ruesew Portfolio 1
- mypharma
- TW Growth
- markastevenson Portfolio 1
- How To Play A Rate Hike
- killer bees
- AFree Portfolio 1
- PhishyAl's Portfolio
- nhjackson Portfolio 1
- BACKUP PORTFOLIO
- Schroeders Portfolio
- youngmiss Portfolio 1
- trader6 Portfolio 1
- kEV;S CURRENT HAND
- acsutherland Portfolio 1
- bryon Portfolio 1
- JOtter Portfolio 1
- SUPRATRADE BIOTECH
- the portfolio
- salvatore Portfolio 1
- Tom Bell Portfolio 1
- show more
- 340
- beau2006
- chuck riebe Portfolio 1
- swrcurrent
- Tung Thai
- aapl
- coyote Portfolio 1
- smtm
- BMO Investment
- mcD
- Scotts' MadMoney
- Ellen's Portfolio
- 5 Breakthrough Drugs for 2007
- j_b Portfolio 1
- MeriBrad
- sobiech
- Wilanow World Stocks
- MAFV Portfolio 1
- sailor1 Portfolio
- neo
- sailboat Portfolio 1
- StartUp
- Tom Van Meter Portfolio 1
- Homework
- StockpickrDotCom Portfolio 1
- W FRAZIER BRINLEY Portfolio 1
- Women of Worth-Trading
- kboerner Portfolio 1
- 2007 stock run
- my updated portfolio
- omeow Portfolio 1
- Wandas
- rcm727 Portfolio 1
- Gangbusters
- Barron's Summary 2-26-07
- Economic Indicator - Rate Hike/Recession/Inflation
- deetharris Portfolio 1
- wacman Portfolio 1
- diamondPortfolio 1
- only maybe
- WH Portfolio
- justin06 Portfolio 1
- rdrake Portfolio 1
- TZ's Holdings
- ybormel Portfolio 1
- vision2000 Portfolio 1
- gasgan22 Portfolio 1
- HEMONOSTIX STOCKS
- mustgofaster yield plus allocation
- My 23
- jgbchbum@aol.com Portfolio 1
- News For Selected Stock
- Related stories on theStreet.com
- videos related to etf's
- No videos found
- blogs related to etf's
- GlaxoSmithKline Takes ...
- Nabi Smoking (NABI, GSK)
- show more
- 22/11/09
- 16/11/09
Why I Love This Stock |
|
Date:11 27 09 |
|
By kjp712: Long. "They are makers of TUMS for relief of heartburn and acid indigestion" |
|
Not yet rated
Rate now:
|
|
By:Dan2009 |
Date:07 08 09 |
Good drug pipes and management |
|
Not yet rated
Rate now:
|
|
By:barrons3 |
Date:06 17 09 |
GSK (GSK) also got a lot of juice on Tuesday on a tough tape, adds Tim Seymour. It may be worth a look. |
|
Not yet rated
Rate now:
|
|
By:barrons3 |
Date:04 29 09 |
Huckman mentioned two companies that make anti-virals: GlaxoSmithKline(GKS), which makes Relenza, and Gilead Sciences (GILD), which gets a 20% royalty for Tamiflu, a drug it makes for Roche. |
|
Not yet rated
Rate now:
|
|
By:Pro |
Date:11 30 -1 |
Biotech Earnings: Gilead: Stephanie Link, director of research for Cramer's Action Alerts Plus Portfolio, dissects biotech earnings and reveals how they're trading Gilead. |
|
Not yet rated
Rate now:
|
|
Date:04 27 09 |
|
Adam Feuerstein: "GlaxoSmithKline (GSK) sells the other flu antiviral medicine, Relenza." Read more here. |
|
Not yet rated
Rate now:
|
|
By:barrons3 |
Date:04 22 09 |
Najarian also liked GlaxoSmithKline(GSK) for going out and buying closely held Stiefel Laboratories for $3.4 billion, including debt. |
|
Not yet rated
Rate now:
|
|
Date:04 16 09 |
|
Adam Feuerstein: "Today's announcement that GlaxoSmithKline (GSK) and Pfizer (PFE) are merging their respective HIV drug businesses is a sign that Glaxo (and perhaps Pfizer as well) is no longer able to compete in the market against Gilead Sciences (GILD)." Read more on TheStreet.com. |
|
Not yet rated
Rate now:
|
|
By:rdjmurrieta |
Date:03 27 09 |
My big-cap Pharma Play. Oh-well. |
|
Not yet rated
Rate now:
|
|
By:sarah z |
Date:01 01 09 |
From a recent Mad Money show:"I'm positive on GSK, although I haven't heard a lot from Obama to really jump start this sector yet." |
|
Not yet rated
Rate now:
|
|
Why I Hate This Stock |
|
By:kl1070 |
Date:08 06 08 |
risky |
|
Not yet rated
Rate now:
|
|
By:Bevy |
Date:03 15 07 |
? |
|
Not yet rated
Rate now:
|
|
By:wandra2 |
Date:02 17 07 |
growth and income |
|
Not yet rated
Rate now:
|
|
By:reg stith |
Date:01 14 07 |
Like the dividend and believe it too be undervalued. Good pipeline. |
|
Not yet rated
Rate now:
|
|
